Cannabinoids in Mental Health Treatment: A Systematic Review and Meta-Analysis
Current evidence on cannabinoids for mental health and substance use disorders remains limited and inconclusive. This systematic review and meta-analysis highlights low-certainty data on efficacy and safety. Clinicians should interpret findings…
Cannabis Extract Shows Anti-Inflammatory and Antidepressant-Like Effects in Mice—But Human Relevance Remains Unproven
A 2024 preclinical study investigated cannabis sativa anti-inflammatory effects using leaf extracts rich in THCA and beta-caryophyllene. The research demonstrated reduced depressive-like behavior and suppressed neuroinflammatory markers in mice. These…
Can Medicinal Plants Help Fight Antibiotic-Resistant Infections? A Review of the Evidence
This 2024 review examines medicinal plants antibacterial wound healing properties and their potential against antibiotic-resistant infections. While promising in vitro, clinical evidence remains limited. Natural biopolymer wound dressings show more…
Herbal Supplements and Surgery: What Your Anesthesiologist Needs to Know
Herbal supplements perioperative interactions pose important risks during surgery. Many patients do not disclose their herbal use, increasing potential anesthesia complications. Understanding these interactions helps improve surgical safety and outcomes.
First Placebo-Controlled Trial of Cannabigerol Finds Reduced Anxiety and Stress—But With Important Caveats
The 2024 CBG anxiety stress trial found that a single 20 mg dose of cannabigerol reduced anxiety and stress in healthy adults without intoxication. This placebo-controlled study provides the first controlled human evidence supporting CBG's anxiolytic…
Cannabinoids for Acute Pain: Strong Biology, Weak Clinical Evidence
Cannabinoid analgesia acute pain research reveals a strong biological basis but inconsistent clinical evidence. The endocannabinoid system offers promising pain modulation pathways. However, current trials lack sufficient power to confirm cannabinoids'…
CBD for Oral Diseases: Promising Preclinical Science, But Clinical Evidence Is Still Missing
This 2024 review explores cannabidiol pharmacology oral medicine and its therapeutic potential in oral diseases. The evidence is mainly preclinical, with no clinical trials yet. CBD shows promise in periodontal and oral cancer research but lacks clinical…
Topical CBD Shows Promise for Skin and Eye Conditions, But Dosing Evidence Remains Thin
Topical CBD evidence reveals potential benefits for skin and eye conditions like atopic dermatitis and glaucoma. Despite encouraging biological signals, dosing evidence remains thin. More clinical trials are needed to establish effective treatment…
Evidence-Based Cannabis for Dementia-Related Behavioral Agitation
A meta-analysis of 10 RCTs shows medical cannabis can reduce dementia-related agitation—a behavioral symptom that devastates both patients and caregivers. Cannabinoids showed effectiveness comparable to antipsychotics but with a safer profile, especially…
Cannabinoids for Nerve Pain: What the Best Clinical Evidence Says About Sleep and Pain Relief
This review of cannabinoid therapy neuropathic pain examines a 2022 meta-analysis of eight randomized controlled trials involving 1,051 patients. The findings showed significant improvements in sleep quality and pain intensity. The study highlights…